fang zhi yao yi zhi xing ping jia ji yu yu tiao zhan
chen yan zhong ;

..............page:881-882

Current Status and Future Development of Clinical Laboratories for Bioequivalence Analysis of Generic Drugs in China
PANG Jianxin;WU Ting;XU Zhongyuan;LIU Shuwen;School of Pharmaceutical Sciences;Southern Medical University;Center of Drug Clinical Trials;Nanfang Hospital;Southern Medical University;

..............page:883-889

yao xue jin zhan za zhi 2017 nian zheng ding qi shi

..............page:889

Abbreviated New Drug Application Filing Strategy for Generic Drugs Required to Perform Quality Consistency Evaluation in China
LI Youfeng;LU Hui;ZHANG Jiaai;QIU Mingfeng;School of Pharmacy;Shanghai Jiao Tong University;Frontage Laboratories;Hangzhou Bio-Scimed Pharma-Tech Corp.;Ltd.;

..............page:890-896

Application of Raman Technique in Pharmaceutical Reverse Engineering
TIAN Fang;ZIMMERMANN Anne;MCGOVERIN Cushla;WANG Ting;FENG Min;LIN Huaqin;HONG Jianwen;LIN Shengwen;Nycrist Pharmatech Limited;Pharmaceutical Engineering Committee of Guangdong Pharmaceutical Association;Guangzhou Production-study-research Technology Innovation Alliance on Quality Consistency Evaluation for Drugs;The University of Auckland;Guangzhou Yipinhong Pharmaceutical Co.;Ltd.;Sun Yat-sen University;Guangdong Pharmaceutical University;Guangdong Institute for Drug Control;

..............page:897-905

Development Strategy for Therapeutic Equivalence Evaluation of Special Dosage Forms
ZHU Haijian;SU Yijie;LIN Fuxiang;CAI Linhui;YE Ying;LS Pharmaceuticals Co.;Ltd.;Xiamen LP Pharmaceutical Co.;Ltd.;

..............page:906-915

Application of Multivariate Conf idence Interval Method and Model Dependent Method in Similarity Comparison of Dissolution Prof iles
ZHANG Hailong;YAN Quanhong;ZHU Haijian;PAN Weisan;LIANG Chaofeng;WANG Ting;Shenzhen Youpuhui Pharmaceutical Co.;Ltd.;Society for Pharmaceutical Engineering;Guangdong Institute for Drug Control;LS Pharmaceuticals Co.;Ltd.;Shenyang Pharmaceutical University;Guangzhou Union for Industry-University-Research Cooperation in Technology Innovation of Industry Controlled Correspondence Related to Generic Drug Development;Guangzhou General Pharmaceutical Research Institute;Guangzhou Yipinhong Pharmaceutical Co.;Ltd.;

..............page:916-923

Refl ections on the Research of Related Substances in Consistency Evaluation for Generic Drugs
ZHOU Lichun;Beijing Institute For Drug Control;

..............page:924-927

Research and Development of Novel Antidepressants
JIN Chuanfei;ZHANG Yingjun;ZHANG Ji;HEC Research and Development Center;

..............page:928-937

Statistical Analysis and Implication of FDA’s Warning Letters on CGMP for Medical Products
AN Jinmeng;MAI Liyi;CHEN Xin;JIANG Jie;Institute of Dongguan-Jinan University;

..............page:938-944

yao xue jin zhan za zhi zheng gao qi shi

..............page:944

Development Modes and Valuation for Innovative Drugs in China( II
ZHANG Jiabo;XU Jiaxi;Institute of Industrial Securities;

..............page:945-953

An Overview of New Drugs Approved in the US, EU and Japan in November 2016
SUN Yousong;

..............page:959-962

yao xue jin zhan 2016 nian di 40 juan zong mu ci ( di 1~12 qi )

..............page:963-967